Finland· FI-REL-REL3265

Lorabid

A loracarbef product containing loracarbef, registered in Finland by Eli Lilly Finland Oy Ab.

ATC J01DC08

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedLorabidATCJ01DC08REGISTER NO.FI-REL-REL3265PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Loracarbef
Manufacturer
Eli Lilly Finland Oy Ab
Country
Finland (FI)
ATC code
J01DC08
ATC class
Loracarbef
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for loracarbef.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Loracarbef · interactions on record

10 records

  • 10 moderate

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • WarfarinB01AA03moderate
  • Levonorgestrel and ethinylestradiolG03AA07moderate
  • Desogestrel and ethinylestradiolG03AA09moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J01DC08

Loracarbef, as other registers publish it.

All loracarbef products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dc371670-359e-4f9d-acf9-ee867da10159
GET /v1/drugs/dc371670-359e-4f9d-acf9-ee867da10159?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.6",
  "form": "rakeet oraalisuspensiota varten",
  "route": null,
  "ddd_unit": "g",
  "strength": "40 mg/ml",
  "atc_label": "lorakarbefi",
  "ma_number": "11666",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL3265",
  "authorised_at": "1995-02-06"
}

See everything about loracarbef.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.